Diabetes in India - Kantar Health

DIABETES IN INDIA– a figure that is growing rapidly. Specialistcommunity sites like D-book enable patientsnot only to share their experiences with fellowpatients but to benefit from doctors’ expertiseusing video conferencing and online discussion.“ … diabetes patients in Indiaare increasingly connectingwith other patientsusing social media …”Because wealthier Indian patients tend to haveaccess to the internet, patient types in Indiawere re-segmented using the Digital Life (www.tnsdigitallife.com/) online classifications todetermine the extent of stakeholders’ activityand engagement online, and to see whetherusing mainly online communications wouldimprove patients’ engagement and compliance.Almost three-quarters of the sample havestrong engagement in digital campaigns.Interestingly, over half of the Indian patientgroup, including non-compliant patients, fellinto the ‘aspirer’ category with high onlineinvolvement. Therefore, they would be open tothe use of social media and online chat for diseaseeducation and marketing even although theydid not use these channels as much as some ofthe other groups. Another quarter of patientswere power internet users or ‘influencers’.Pharma companies looking to educate Type 2diabetes patients in India or encourage them tocomply with a treatment regimen should explorehow to get messages across digitally. It will alsobe particularly important to utilise available datato monitor changes in epidemiology, patienteducation and both health-related quality of lifeand economic outcomes across all the diabeteshotspots. While stopping the spread of the diseaseisn’t possible, we can at least choose the bestmeans to educate patients, help them come toterms with their disease, and help them managetheir symptoms to achieve a better quality of life.The AuthorReena Thapar is a research managerat Kantar Health. She can be contactedat reena.thapar@kantarhealth.com.Diabetes prevalence (%)Adults aged 20-79 (in 1,000s)Adults with diabetes aged20-79 (in 1,000s)Africa 3.80 386,298 14,722Europe 8.08 653,233 52,771Middle East/North Africa 9.15 356,438 32,603North America 11.72 321,968 37,737South America 8.68 289,539 25,134Southeast Asia 8.34 856,282 71,407Western Pacific 8.54 1,544,462 131,896Source: International Diabetes Federation 2012Rank* In millionsCountryT2DPopulation*Source: International Diabetes Federation 20122011 2030 2030 minus 2011Prevalence(%)T2DPopulation*Prevalence(%)A T2DPopulation*A in T2DPrevalence1 India 61.3 8.3 101.2 9.9 39.9 1.6%2 China 90.0 9.3 129.7 12.1 39.7 2.8%3 Bangladesh 8.4 9.6 16.8 13.3 8.4 3.7%4 Brazil 12.4 9.7 19.6 12.3 7.2 2.6%5 Mexico 10.3 14.8 16.4 17.6 6.1 2.8%6 USA 23.7 10.9 29.6 11.8 5.9 0.9%7 Pakistan 6.3 6.7 11.4 7.8 5.1 1.0%8 Egypt 7.3 15.2 12.4 17.8 5.1 2.7%9 Indonesia 7.3 4.7 11.8 5.9 4.5 1.2%10 Iran 4.7 9.3 8.4 13.1 3.7 3.8%Pharmaceutical Market Europe November 2012 www.pmlive.com/pme 33